Venture Life Group PLC Cash Flow Conversion Efficiency
Venture Life Group PLC cash flow conversion efficiency. Based on the latest financial reports, Venture Life Group PLC (VLG) has a cash flow conversion efficiency ratio of -0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-955.00K ≈ $-116.20 USD) by net assets (GBX81.42 Million ≈ $9.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Venture Life Group PLC (2010–2025)
Cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2025. This chart illustrates how Venture Life Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Venture Life Group PLC (VLG) share price today for real-time trading data and today's change.
Venture Life Group PLC Cash Flow Conversion Ratio Explained
Venture Life Group PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Venture Life Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Venture Life Group PLC ranked by their cash flow conversion efficiency. Also see VLG company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Energy Metals Corp
V:GEMC
|
-0.028x |
|
Gentlemens Equity S.A.
PA:MLGEQ
|
N/A |
|
Brave Bison Group PLC
LSE:BBSN
|
0.021x |
|
Allergy Therapeutics
LSE:AGY
|
-2.755x |
|
Satis Group S.A.
WAR:STS
|
0.000x |
|
Maven Income and Growth VCT 4 PLC
LSE:MAV4
|
-0.007x |
|
Spectra Systems Corp
LSE:SPSY
|
0.210x |
|
CREATIVEF. G.S.A-K ZY-23
F:19F
|
0.032x |
Annual Cash Flow Conversion Efficiency for Venture Life Group PLC (2010–2025)
The table below shows the annual cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2025. Review how much free cash does Venture Life Group PLC generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX81.42 Million ≈ $9.91K |
GBX-264.00K ≈ $-32.12 |
-0.003x | -102.93% |
| 2024-12-31 | GBX75.41 Million ≈ $9.18K |
GBX8.35 Million ≈ $1.02K |
0.111x | +2.73% |
| 2023-12-31 | GBX76.25 Million ≈ $9.28K |
GBX8.22 Million ≈ $1.00K |
0.108x | +46.53% |
| 2022-12-31 | GBX75.66 Million ≈ $9.21K |
GBX5.57 Million ≈ $677.22 |
0.074x | +795.58% |
| 2021-12-31 | GBX73.16 Million ≈ $8.90K |
GBX601.00K ≈ $73.12 |
0.008x | -78.11% |
| 2020-12-31 | GBX72.11 Million ≈ $8.77K |
GBX2.71 Million ≈ $329.24 |
0.038x | -49.55% |
| 2019-12-31 | GBX32.82 Million ≈ $3.99K |
GBX2.44 Million ≈ $297.00 |
0.074x | +902.63% |
| 2018-12-31 | GBX32.08 Million ≈ $3.90K |
GBX238.00K ≈ $28.96 |
0.007x | +225.28% |
| 2017-12-31 | GBX14.19 Million ≈ $1.73K |
GBX-84.00K ≈ $-10.22 |
-0.006x | +81.40% |
| 2016-12-31 | GBX14.36 Million ≈ $1.75K |
GBX-457.00K ≈ $-55.60 |
-0.032x | +60.39% |
| 2015-12-31 | GBX13.80 Million ≈ $1.68K |
GBX-1.11 Million ≈ $-134.93 |
-0.080x | +43.47% |
| 2014-12-31 | GBX15.65 Million ≈ $1.90K |
GBX-2.22 Million ≈ $-270.60 |
-0.142x | +92.35% |
| 2013-12-31 | GBX557.00K ≈ $67.77 |
GBX-1.03 Million ≈ $-125.93 |
-1.858x | +54.27% |
| 2012-12-31 | GBX127.00K ≈ $15.45 |
GBX-516.00K ≈ $-62.78 |
-4.063x | -164.65% |
| 2011-12-31 | GBX312.00K ≈ $37.96 |
GBX-479.00K ≈ $-58.28 |
-1.535x | -30.19% |
| 2010-12-31 | GBX212.00K ≈ $25.79 |
GBX-250.00K ≈ $-30.42 |
-1.179x | -- |
About Venture Life Group PLC
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermat… Read more